Randomised controlled trial (RCT): Conservative voice treatment (CVT) versus electrostimulation therapy (EST) for unilateral vocal cord paresis (UVCP)

ISRCTN ISRCTN17141238
DOI https://doi.org/10.1186/ISRCTN17141238
Secondary identifying numbers N/A
Submission date
13/09/2004
Registration date
11/10/2004
Last edited
10/12/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Ear, Nose and Throat
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Martin Ptok
Scientific

Klinik für Phoniatrie und Pädaudiologie
Medizinische Hochschule Hannover - OE 6510
C.-Neuberg-Str.1
Hannover
30625
Germany

Phone +49 (0)511 532 9104
Email Ptok.Martin@MH-Hannover.de

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study acronymCVT vs EST in UVCP: RCT
Study objectivesAdded as of 10/12/2008:
Electrical stimulation therapy is as effective as voice therapy in patients with unilateral recurrent laryngeal nerve paresis.
Ethics approval(s)The study was approved by the Ethics Committee of the Hannover Medical School.
Health condition(s) or problem(s) studiedVocal cord paresis
InterventionConservative voice treatment versus electrostimulation therapy
Intervention typeOther
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2003
Completion date31/12/2003

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexBoth
Target number of participantsAdded as of 10/12/2008: 90
Key inclusion criteriaPatients with unilateral vocal cord paresis
Key exclusion criteriaAdded as of 10/12/2008:
1. Voice therapy or any other therapy prior to T0
2. Paresis onset less than 2 weeks or more than 6 months prior to therapy
3. Age under 18 years
4. Paresis following resection of the recurrent nerve
5. Pareses due to muscle or joint injuries
6. Hearing loss 40 dB in the 500–3000 Hz range
7. Presence of other conditions possibly interfering with the therapy, such as cognitive deficits or other serious diseases
Date of first enrolment01/01/2003
Date of final enrolment31/12/2003

Locations

Countries of recruitment

  • Germany

Study participating centre

Klinik für Phoniatrie und Pädaudiologie
Hannover
30625
Germany

Sponsor information

Phoniatry and Paedaudiology Clinic, Hannover Medical School (Germany)
Research organisation

Martin Ptok
Klinik für Phoniatrie und Pädaudiologie
Medizinische Hochschule Hannover - OE 6510
C.-Neuberg-Str. 1
Hannover
30625
Germany

Website http://www.MH-Hannover.de
ROR logo "ROR" https://ror.org/00f2yqf98

Funders

Funder type

Other

Added as of 10/12/2008:

No information available

Hannover Medical School, Clinical Department of Communication Disorders (Germany)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article final results 01/08/2008 Yes No